Login
$MRK
$144.82 After hours

$MRK SEC Filings

Filed On Filing
13 Nov 2026 13F-HR
12 Nov 2026 144
04 Nov 2026 10-Q
03 Nov 2026 Form 4: Diaz Paul J, Director

Granted 613.073 Phantom Stock ($91.7K)

03 Nov 2026 Form 3: Diaz Paul J, Director

Holds 200 shares of Common Stock

02 Nov 2026 144
29 Oct 2026 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

22 Oct 2026 Form 3/A: Maraldo David R., EVP & Pres. MMD

Holds 2,870.7727 shares of Common Stock - 401(k) Plan

15 Oct 2026 25-NSE
13 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

____________________________________________________________________________

01 Oct 2026 Form 4: Seidman Christine E, Director

Granted 55.9149 Phantom Stock ($8.12K)

01 Oct 2026 Form 4: Karsanbhai Surendralal Lanca, Director

Granted 111.8299 Phantom Stock ($16.3K)

01 Oct 2026 Form 4: Coe Mary Ellen, Director

Granted 206.4552 Phantom Stock ($30K)

01 Sep 2026 Form 3: Gupta Gaurav K, EVP, CIDO

Holds 750 shares of Common Stock

13 Aug 2026 Form 4: Guindo Chirfi, EVP, Access, Policy & Comms

Sold 10,000 shares ($1.35M)

13 Aug 2026 144
13 Aug 2026 Form 4: Zachary Jennifer, EVP, General Counsel

Received 54,927 shares by exercise or conversion ($6.03M) · Sold 80,315 shares ($10.7M)

12 Aug 2026 144
12 Aug 2026 144
12 Aug 2026 Form 4: DeLuca Richard R., EVP&Pres, Merck Animal Heallth

Sold 20,784 shares ($2.71M) · Sold 12,837 shares ($1.69M) · Sold 11,699 shares ($1.54M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support